Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 97 filers reported holding Y-MABS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $651,848 | -18.8% | 119,605 | +1.1% | 0.00% | – |
Q2 2023 | $803,162 | +42.5% | 118,286 | +5.1% | 0.00% | – |
Q1 2023 | $563,780 | +1.9% | 112,531 | -0.7% | 0.00% | – |
Q4 2022 | $553,099 | -66.2% | 113,340 | -0.0% | 0.00% | – |
Q3 2022 | $1,634,000 | +5.2% | 113,355 | +10.4% | 0.00% | – |
Q2 2022 | $1,553,000 | +25.4% | 102,657 | -1.4% | 0.00% | – |
Q1 2022 | $1,238,000 | -26.1% | 104,135 | +0.8% | 0.00% | – |
Q4 2021 | $1,675,000 | -43.4% | 103,345 | -0.3% | 0.00% | -100.0% |
Q3 2021 | $2,958,000 | -4.5% | 103,634 | +13.1% | 0.00% | 0.0% |
Q2 2021 | $3,097,000 | +1.5% | 91,626 | -9.2% | 0.00% | 0.0% |
Q1 2021 | $3,051,000 | -42.8% | 100,910 | -6.4% | 0.00% | 0.0% |
Q4 2020 | $5,335,000 | +32.2% | 107,759 | +2.5% | 0.00% | 0.0% |
Q3 2020 | $4,035,000 | -10.7% | 105,109 | +0.5% | 0.00% | 0.0% |
Q2 2020 | $4,519,000 | +102.6% | 104,603 | +22.4% | 0.00% | 0.0% |
Q1 2020 | $2,231,000 | -14.8% | 85,463 | +1.9% | 0.00% | 0.0% |
Q4 2019 | $2,620,000 | +70.5% | 83,832 | +42.1% | 0.00% | – |
Q3 2019 | $1,537,000 | +16.3% | 59,001 | +2.0% | 0.00% | – |
Q2 2019 | $1,322,000 | +149.4% | 57,829 | +186.0% | 0.00% | – |
Q1 2019 | $530,000 | – | 20,220 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 191,176 | $2,271,000 | 2.63% |
Sofinnova Investments, Inc. | 2,194,278 | $26,068,000 | 1.98% |
MPM BioImpact LLC | 443,702 | $5,271,000 | 1.42% |
Soleus Capital Management, L.P. | 238,982 | $2,839,000 | 0.37% |
Lombard Odier Asset Management (Switzerland) SA | 221,774 | $2,635,000 | 0.21% |
Artal Group S.A. | 400,000 | $4,752,000 | 0.20% |
Polar Capital Holdings Plc | 2,877,671 | $34,187,000 | 0.15% |
ASHFORD CAPITAL MANAGEMENT INC | 106,770 | $1,268,000 | 0.14% |
Cormorant Asset Management, LP | 150,000 | $1,782,000 | 0.14% |
Virtus ETF Advisers LLC | 23,646 | $281,000 | 0.13% |